To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: ATPase Ca++ transporting plasma membrane 4 (ATP2B4; PMCA4)

Cardiovascular disease

INDICATION: Cardiomyopathy

Mouse studies suggest inhibiting ATP2B4 could help treat hypertrophic

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE